| 6th Feb 2014 7:00 am |
RNS |
Pipeline Table |
| 6th Feb 2014 7:00 am |
RNS |
Final Results |
| 5th Feb 2014 9:00 am |
RNS |
Notice of Results |
| 3rd Feb 2014 4:30 pm |
RNS |
Total Voting Rights |
| 3rd Feb 2014 7:00 am |
RNS |
AZ completes BMS diabetes acquisition |
| 27th Jan 2014 10:30 am |
RNS |
Holding(s) in Company |
| 22nd Jan 2014 7:00 am |
RNS |
Xigduo approved in EU for type 2 diabetes |
| 17th Jan 2014 10:42 am |
RNS |
Replacement re block listing application |
| 17th Jan 2014 7:00 am |
RNS |
Block Listing Application |
| 14th Jan 2014 7:00 am |
RNS |
AstraZeneca provides strategy update at JP Morgan |
| 13th Jan 2014 7:00 am |
RNS |
US FDA APPROVES FARXIGAT (DAPAGLIFLOZIN) |
| 9th Jan 2014 7:00 am |
RNS |
US FDA Approval of Farxiga (dapagliflozin) |
| 2nd Jan 2014 4:00 pm |
RNS |
Total Voting Rights |
| 27th Dec 2013 7:13 am |
RNS |
AZ and Shionogi extend Crestor agreement |
| 19th Dec 2013 2:00 pm |
RNS |
Director/PDMR Shareholding |
| 19th Dec 2013 7:50 am |
RNS |
AZ to acquire BMS share of diabetes assets |
| 17th Dec 2013 6:13 pm |
RNS |
STATEMENT ON ESOMEPRAZOLE STRONTIUM LAUNCH IN US |
| 13th Dec 2013 7:14 am |
RNS |
Top Line Results From Phase III Study of Lesinurad |
| 13th Dec 2013 7:00 am |
RNS |
FDA Advisory Committee Recommends Dapagliflozin |
| 12th Dec 2013 7:00 am |
RNS |
FDA Advisory Committee Votes on Metreleptin |
| 6th Dec 2013 7:00 am |
RNS |
European Commission Approves Fluenz Tetra |
| 2nd Dec 2013 3:00 pm |
RNS |
Blocklisting Interim Review |
| 22nd Nov 2013 1:42 pm |
RNS |
XIGDUO POSITIVE CHMP OPINION FOR TYPE 2 DIABETES |
| 19th Nov 2013 7:00 am |
RNS |
NDA for Naloxegol accepted by US FDA |
| 1st Nov 2013 4:00 pm |
RNS |
Total Voting Rights |
| 1st Nov 2013 1:45 pm |
RNS |
Director/PDMR Shareholding |
| 31st Oct 2013 7:02 am |
RNS |
US Court Decision in Pulmicort Respules Litigation |
| 31st Oct 2013 7:01 am |
RNS |
Marc Dunoyer Appointed Chief Financial Officer |
| 31st Oct 2013 7:00 am |
RNS |
3rd Quarter Results |
| 30th Oct 2013 9:00 am |
RNS |
Notice of Results |
| 30th Oct 2013 7:00 am |
RNS |
ASTRAZENECA ADVANCES BENRALIZUMAB TO PHASE III |
| 22nd Oct 2013 7:00 am |
RNS |
AstraZeneca starts phase III study for selumetinib |
| 15th Oct 2013 7:00 am |
RNS |
Medimmune acquires Spirogen |
| 7th Oct 2013 7:00 am |
RNS |
MedImmune completes Amplimmune acquisition |
| 1st Oct 2013 4:00 pm |
RNS |
Total Voting Rights |
| 30th Sep 2013 7:01 am |
RNS |
MAA FOR OLAPARIB ACCEPTED BY EMA |
| 27th Sep 2013 7:00 am |
RNS |
MAA APPLICATION FOR NALOXEGOL ACCEPTED |
| 20th Sep 2013 12:54 pm |
RNS |
Fluenz Tetra receives positive CHMP opinion in EU |
| 4th Sep 2013 7:00 am |
RNS |
Starts phase III clinical programme for olaparib |
| 2nd Sep 2013 3:00 pm |
RNS |
Total Voting Rights |
